Literature DB >> 2363914

Management of the paralyzed lower eyelid by implanting auricular cartilage.

M May1, D F Hoffmann, G F Buerger, D B Soll.   

Abstract

The success of a procedure to reanimate paralyzed eyelids is determined by the functional and cosmetic results. When the cornea is covered during blinking and sleeping, function has been restored, while a pleasing cosmetic result has been achieved if the eyes appear symmetrical when the lids are open. Several procedures have been developed to restore closure of the paralyzed upper eyelid (implantation of gold weights or open wire springs) or to correct lower lid lagophthalmos and ectropion (lower lid tightening with a Bick procedure or insertion of a closed eyelid spring). In some cases, even a combination of the Bick procedure and insertion of a spring may be insufficient to correct lower lid droop; therefore, we developed a technique to place cartilage into the lower eyelid to correct lid droop. The procedure, suggested by one of us (D.B.S.), has been performed on 51 patients to date. This article reviews our experience with these 51 consecutive patients.

Entities:  

Mesh:

Year:  1990        PMID: 2363914     DOI: 10.1001/archotol.1990.01870070034005

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  4 in total

1.  [Surgical treatment of paralytic lagophthalmos].

Authors:  T Schrom; F Bast
Journal:  HNO       Date:  2010-03       Impact factor: 1.284

2.  Gold weights as upper eyelid implants for facial paralysis.

Authors:  Gauri Belsare
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2010-06-04

3.  Effectiveness of the lower eyelid suspension using fascia lata graft for the treatment of lagophthalmos due to facial paralysis.

Authors:  Selam Yekta Sendul; Halil Huseyin Cagatay; Burcu Dirim; Mehmet Demir; Zeynep Acar; Ali Olgun; Efe Can; Dilek Guven
Journal:  Biomed Res Int       Date:  2015-03-04       Impact factor: 3.411

4.  Temporary ectropion therapy by adhesive taping: a case study.

Authors:  Thomas Schrom; Anke Habermann
Journal:  Head Face Med       Date:  2008-07-21       Impact factor: 2.151

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.